NTN1 and neoplasm: Whatever the mechanism, because there is an increasing literature describing EMT as a major player in resistance to chemotherapy and immune checkpoint inhibitors2,28, the observation that treatment with NP137 inhibits features of tumour EMT argues for the clinical assessment of combinations of the anti-netrin-1 mAb with conventional therapies to interfere with tumour progression.